News | November 26, 2022
India’s plan for containment of AMR focuses on an integrated One Health approach: Dr. Bharti
It serves to leverage the strengths of various institutions to coordinate AMR surveillance lab networks
It serves to leverage the strengths of various institutions to coordinate AMR surveillance lab networks
The product is expected to be launched by Q4 FY23.
Q2 FY23 business performance has been slow primarily due to lower volume offtake from pharmaceutical manufacturers
Value chain collaboration aims to foster a circular ecosystem and reduce the carbon footprint of single-use surgical instruments molded in Ixef PARA.
The company has successfully developed Methyl salicylate using Flow Chemistry and successfully erected a Flow reactor at Jhagadia plant and expects to start production from Q3 FY23
Ketorolac Tromethamine is advised for the short-term management of moderately severe acute pain in adult patients
API platform to comprise of RA Chem Pharma, ZCL Chemicals and Avra Laboratories
This is the first injectable product approval from our General Sterile Facility (F-3) which was inspected in August, 2022.
The company currently supplies one product to the US market that contributes low- single digit revenue to Jubilant Pharmova revenue
Frazier led the company for 10 years as President and Chief Executive Officer, from 2011 through 2021.
Subscribe To Our Newsletter & Stay Updated
